View |
|
DR-XY34421
|
Omeprazole
|
Omed 20
|
20 mg
|
Capsule
|
Proton Pump Inhibitors
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
02 March 2023
|
25 March 2028
|
View |
DR-XY34422_PI_01.pdf
|
DR-XY34422
|
Valproic Acid
|
Depakene
|
250mg/5mL
|
Syrup
|
Anticonvulsant
|
P.T. Abbott Indonesia
|
Indonesia
|
Automatic Renewal
|
09 January 2023
|
25 March 2028
|
View |
|
DR-XY34424
|
Ginkgo Biloba EGb 761
|
Tebonin Forte
|
120mg
|
Film Coated Tablet
|
Neurotropic Agent
|
Dr. Willmar Schwabe GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release Extension)
|
27 April 2022
|
27 March 2025
|
View |
|
DR-XY34427
|
Homatropine Hydrobromide
|
Hemasol
|
20mg/mL(2% w/v)
|
Ophthalmic solution
|
Anticholinergic
|
Laboratorios Ashford Lda.
|
China
|
Renewal
|
29 June 2024
|
01 April 2030
|
View |
|
DR-XY34430
|
D-Alpha Tocopheryl Acid Succinate+Korean Ginseng+ Bee Pollen +Lecithin+Calcium Pantothenate
|
Korgivit-E Forte
|
330.58 mg/ 40 mg/ 150 mg/ 120 mg/ 60 mg
|
Capsule
|
Vitamins
|
DIAMOND LABORATORIES INC.
|
Philippines
|
Automatic Renewal
|
13 February 2023
|
01 April 2028
|
View |
|
DR-XY34445
|
Quinapril Hydrochloride
|
Quinapro
|
10 mg
|
Film-Coated Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
26 July 2023
|
13 August 2028
|
View |
|
DR-XY34446
|
Glimepiride
|
Acotril
|
2 mg
|
Tablet
|
Oral Hypoglycemic (Sulfonylureas)
|
Lloyd Laboratories, Inc./Pharma Nutria N.A.
|
Philippines
|
Automatic Renewal
|
01 February 2023
|
09 April 2028
|
View |
|
DR-XY34449
|
Tramadol Hydrochloride
|
Tandol
|
50 mg/mL (100mg/2mL)
|
Solution for Injection
|
-
|
Dae Hwa Pharm. Co., Ltd.
|
Korea
|
-
|
01 February 2021
|
03 April 2026
|
View |
|
DR-XY34453
|
Salbutamol (As Sulfate) + Guaifenesin
|
Salventin
|
1mg/50mg per 5mL
|
Syrup
|
-
|
La Croesus Pharma Inc.
|
Philippines
|
-
|
02 October 2020
|
04 April 2025
|
View |
|
DR-XY34457
|
Iopamidol
|
Iopamiro
|
612mg/mL(equivalent to 300mg Iodine) Solution for Injection (IV)
|
Solution For Injection (Ia/Iv)
|
Water soluble, nephrotropic, low osmolar X-ray Contrast Media
|
Patheon Italia S.P.A.
|
Italy
|
Automatic Renewal
|
30 January 2023
|
09 April 2028
|
View |
|
DR-XY34471
|
Cefepime (As Hydrochloride) With Arginine
|
Hapimax
|
500 mg
|
Powder for Injection
|
Antibacterial (Cephalosporin)
|
Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory
|
China
|
Automatic Renewal
|
05 May 2023
|
18 April 2028
|
View |
DR-XY34472_PI_01.pdf
|
DR-XY34472
|
Salbutamol + Guaifenesin
|
Clarituss Plus
|
1mg/50mg / 5mL
|
Syrup
|
Selective Beta-2-Adrenoreceptor Agonists/ Expectorant
|
La Croesus Pharma, Inc.
|
Philippines
|
Automatic Renewal
|
01 February 2023
|
15 April 2028
|
View |
|
DR-XY34473
|
Ranitidine (As Hydrochloride)
|
Ulceptor
|
75 mg
|
Film-Coated Tablet
|
H2-Receptor Antagonist
|
Drugmakers Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 January 2023
|
15 April 2028
|
View |
|
DR-XY34482
|
Phenylephrine Hydrochloride + Chlorphenamine Maleate + Paracetamol
|
Bioflu
|
10 mg / 2 mg / 500 mg
|
Tablet
|
Nasal Decongestant/Antihistamine/Analgesic/Antipyretic
|
United Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 August 2022
|
14 April 2028
|
View |
|
DR-XY34483
|
Zinc
|
E-Zinc
|
20 mg/5 mL (equivalent to 55 mg Zinc sulfate)
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
29 December 2020
|
24 February 2026
|
View |
|
DR-XY34484
|
Zinc
|
E-Zinc
|
27.5 mg/mL (equivalent to 10mg elemental Zinc)
|
Syrup (Oral Drops)
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 December 2020
|
22 February 2026
|
View |
|
DR-XY34485
|
Fluconazole
|
Fleozol
|
150mg
|
Capsule
|
Antimycotics for systemic Use (Triazole Derivatives)
|
Zee Laboratories
|
India
|
Automatic Renewal
|
31 March 2023
|
16 April 2028
|
View |
|
DR-XY34487
|
Bromhexine Hydrochloride
|
Bromex
|
2 mg/mL
|
Solution for Injection (I.M.)
|
Mucolytic
|
Siu Guan Chem. Ind. Co., Ltd.
|
Taiwan
|
Initial (Variation) (Reconstruction)
|
31 July 2024
|
30 June 2027
|
View |
|
DR-XY34492
|
Antazoline hydrochloride / Tetrahydrozoline hydrochloride
|
Allerex
|
500 mcg/400 mcg per mL (0.05%/0.04 % w/v)
|
Ophthalmic Solution
|
Antihistamine/Vasoconstrictor
|
Laboratories Ashford LDA
|
China
|
Renewal
|
04 August 2024
|
27 August 2030
|
View |
|
DR-XY34500
|
Ceftazidime (As Pentahydrate)
|
Hacef
|
1 g
|
Powder For Injection (IM/IV)
|
-
|
Harbin Pharmaceutical Group Co., Ltd.
|
China
|
-
|
20 April 2021
|
18 April 2026
|